Diego F. Wyszynski, MD, MHS, PhD

CEO
Pregistry / CorEvitas
Los Angeles, England, United Kingdom

AstraZeneca (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Gilead (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)GlaxoSmithKline (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Janssen (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Novavax (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Regeneron (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Roche (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)

Presentation(s):

• COVID-19 Vaccine Use During Pregnancy: Accelerating Innovative Evidence Generation Platforms to Meet Current and Future Challenges

  Sunday, August 28, 2022
  10:30 AM – 12:00 PM CEST

• mRNA COVID-19 Vaccination Early in Pregnancy and Risk of Spontaneous Abortion in an International Pregnancy Registry

  Sunday, August 28, 2022
  2:45 PM – 3:00 PM CEST